Increased DNA integrity in colorectal cancer

In Vivo

Volumn 28, Issue 3, 2014, Pages 299-303

  Leszinski, Gloria ^a   Lehner, Julia ^a   Gezer, Ugur ^b   Holdenrieder, Stefan ^a,c  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b Istanbul Science University   (Turkey)

^c UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

ALU repeats; Diagnosis; DNA integrity; Serum colorectal cancer

Indexed keywords

DNA FRAGMENT; REPETITIVE DNA; DNA; TUMOR MARKER;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; DNA INTEGRITY; DNA ISOLATION; DNA STRUCTURE; FEMALE; GASTROINTESTINAL DISEASE; HUMAN; MALE; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; SERUM; BLOOD; CASE CONTROL STUDY; COLORECTAL NEOPLASMS; GENETICS; MIDDLE AGED; YOUNG ADULT;

ADULT; AGED; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; DNA; FEMALE; HUMANS; MALE; MIDDLE AGED; ROC CURVE; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84918509823     PISSN: 0258851X     EISSN: 17917549     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. World Health Organization: World Health Statistics 2013. www.who.int, 2013.
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
3. Siegel R, Naishadham D and Jemal A: Cancer Statistics 2013. CA Cancer J Clin 63: 11-30, 2013.
4. Duffy MJ, van Dalen A, Haglund C, Hansson L, Holinski-Feder E, Klapdor R, Lamerz R, Peltomaki P, Sturgeon C and Topolcan O: Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use. Eur J Cancer 43: 1348-60, 2007.
5. Schwarzenbach H, Hoon DS and Pantel K: Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer 11: 426-437, 2011.
6. Holdenrieder S and Stieber P: Clinical use of circulating nucleosomes. Crit Rev Clin Lab Sci 46: 1-24, 2009.
7. Jahr S, Hentze H, Englisch S, Hardt D, Fackelmayer FO, Hesch RD and Knippers R: DNA fragments in the blood plasma of cancer patients: Quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res 61: 1659-1665, 2001.
8. Umetani N, Kim J, Hiramatsu S, Reber HA, Hines OJ, Bilchik AJ and Hoon DS: Increased integrity of free circulating DNA in sera of patients with colorectal or periampullary cancer: Direct quantitative PCR for ALU repeats. Clin Chem 52: 1062-1069, 2006.
9. Schmidt B, Weickmann S, Witt C and Fleischhacker M: Integrity of cell-free plasma DNA in patients with lung cancer and nonmalignant lung disease. Ann NY Acad Sci 1137: 207-213, 2008.
10. Shi W, Lv C, Qi J, Zhao W, Wu X, Jing R, Wu X, Ju S and Chen J: Prognostic value of free DNA quantification in serum and cerebrospinal fluid in glioma patients. J Mol Neurosci 46: 470-5, 2012.
11. Boddy JL, Gal S, Malone PR, Shaida N, Wainscoat JS and Harris AL: The role of cell-free DNA size distribution in the management of prostate cancer. Oncol Res 16: 35-41, 2006.
12. Umetani N, Giuliano AE, Hiramatsu SH, Amersi F, Nakagawa T, Martino S and Hoon DS: Prediction of breast tumor progression by integrity of free circulating DNA in serum. J Clin Oncol 24: 4270-4276, 2006.
13. Wang BG, Huang HY, Chen YC, Bristow RE, Kassauei K, Cheng CC, Roden R, Sokoll LJ, Chan DW and Shih IM: Increased plasma DNA integrity in cancer patients. Cancer Res 63: 3966-3968, 2003.
14. Chen H, Sun LY, Zheng HQ, Zhang QF and Jin XM: Total serum DNA and DNA integrity: diagnostic value in patients with hepatitis B virus-related hepatocellular carcinoma. Pathology 44: 318-24, 2012.
15. Tomita H, Ichikawa D, Ikoma D, Sai S, Tani N, Ikoma H, Fujiwara H, Kikuchi S, Okamoto K, Ochiai T and Otsuji E: Quantification of circulating plasma DNA fragments as tumor markers in patients with esophageal cancer. Anticancer Res 27: 2737-41, 2007.
16. Gao YJ, He YJ, Yang ZL, Shao HY, Zuo Y, Bai Y, Chen H, Chen XC, Qin FX, Tan S, Wang J, Wang L and Zhang L: Increased integrity of circulating cell-free DNA in plasma of patients with acute leukemia. Clin Chem Lab Med 48: 1651-1656, 2010.
17. Holdenrieder S, Burges A, Reich O, Spelsberg FW and Stieber P: DNA integrity in plasma and serum of patients with malignant and benign diseases. Ann N Y Acad Sci 1137: 162-170, 2008.
18. Stoetzer OJ, Lehner J, Fersching-Gierlich D, Nagel D and Holdenrieder S: Diagnostic relevance of plasma DNA and DNA Integrity for breast cancer. Tumor Biol 2013; published online.
19. Agostini M, Pucciarelli S, Enzo MV, Del Bianco P, Briarava M, Bedin C, Maretto I, Friso ML, Lonardi S, Mescoli C, Toppan P, Urso E and Nitti D: Circulating cell-free DNA: a promising marker of pathologic tumor response in rectal cancer patients receiving preoperative chemoradiotherapy. Ann Surg Oncol 18: 2461-8, 2011.
20. Hauser S, Zahalka T, Ellinger J, Fechner G, Heukamp LC, von Ruecker A, Müller SC and Bastian PJ: Cell-free circulating DNA: Diagnostic value in patients with renal cell cancer. Anticancer Res 30: 2785-9, 2010.
21. Ellinger J, Wittkamp V, Albers P, Perabo FG, Mueller SC, von Ruecker A and Bastian PJ: Cell-free circulating DNA: diagnostic value in patients with testicular germ cell cancer. J Urol 181: 363-371, 2009.
22. Salvianti F, Pinzani P, Verderio P, Ciniselli CM, Massi D, De Giorgi V, Grazzini M, Pazzagli M and Orlando C: Multiparametric analysis of cell-free DNA in melanoma patients. PLoS One 7: e49843, 2012.